Director, Government Affairs Spain at Gilead Sciences

Madrid, Community of Madrid, Spain

Apply Now

Not SpecifiedCompensation

Senior (5 to 8 years), Expert & Leadership (9+ years)Experience Level

Full TimeJob Type

UnknownVisa

Pharmaceuticals, HealthcareIndustries

Requirements

Degree in Public Health, Political Science, Pharmaceuticals, Law, or related field
5+ years of experience in health policy, government affairs, or public health advocacy
Strong understanding of Spanish healthcare systems and policy-making processes
Proven ability to build and maintain trustful relationships with policy makers and parliamentarians
Excellent communication, negotiation, and project management skills
Fluency in Spanish and professional proficiency in English

Responsibilities

Develop and execute strategic plans related to national and local healthcare and pharmaceutical policies, legislation and regulations
Lead policy advocacy initiatives to influence healthcare policies that improve patient access and support innovation in key therapeutic areas, ensuring compliance with all internal and external standards
Establish and maintain relationships with government stakeholders, including policymakers, regulatory authorities, and policy advisors, to advocate for Gilead’s mission and priorities at national and regional levels
Monitor and analyze policy and legislative developments, identifying opportunities and risks for Gilead’s portfolio and strategic priorities
Collaborate cross-functionally with Medical Affairs, Market Access, Public Affairs, and Marketing to ensure integrated policy positions and evidence-based arguments underpin all policy proposals
Represent Gilead in external fora, ensuring the company’s interests are effectively communicated and protected
Manage projects and budgets effectively, ensuring timely delivery and resource optimization
Adopt an outcome-based mindset, ensuring every activity contributes to measurable policy progress and business impact
Leverage policy-relevant evidence to support advocacy and strategic decision-making
Analyze health system data, policy trends, and stakeholder landscapes to identify actionable insights
Prepare reports, dashboards, and briefing materials to inform internal teams and external engagements
Participate in global initiatives when relevant, sharing best practices and rolling out global initiatives in the affiliate

Skills

Government Affairs

Policy Advocacy

Healthcare Policy

Pharmaceutical Regulation

Stakeholder Engagement

Strategic Planning

Legislation

Public Health Advocacy

Gilead Sciences

Develops and commercializes biopharmaceuticals

About Gilead Sciences

Gilead Sciences focuses on discovering, developing, and commercializing medicines for various medical conditions, including HIV/AIDS, liver diseases, cancer, inflammatory and respiratory diseases, and cardiovascular issues. The company conducts extensive research and development to create new therapies, which are then marketed to healthcare providers, hospitals, and pharmacies after receiving regulatory approval. Gilead differentiates itself from competitors through its strong commitment to R&D and strategic partnerships, such as with SAP Ariba, to enhance its operations and product offerings. The company's goal is to improve health equity and access to care globally, working with communities to ensure that its medicines reach those in need.

Foster City, CaliforniaHeadquarters

1987Year Founded

$15,873.6MTotal Funding

IPOCompany Stage

Biotechnology, HealthcareIndustries

10,001+Employees

Benefits

Paid family time off and paid parental time off

Generous 401(k) contribution matching

Comprehensive medical plans that cover both physical and mental healthcare

Global Wellbeing Reimbursement

Time Off

Global Volunteer Day

Giving Together Program

Employee Support Programs

Flexible Work Options

Risks

Increased competition in HIV treatment from ViiV Healthcare's expanding drug portfolio.

Regulatory scrutiny over drug pricing could impact Gilead's U.S. market operations.

Patent expirations, like Truvada's, lead to increased generic competition and revenue loss.

Differentiation

Gilead's lenacapavir is recognized as the 2024 Breakthrough of the Year for HIV care.

Partnerships with LEO Pharma and Tubulis enhance Gilead's focus on inflammatory and cancer therapies.

Gilead's commitment to health equity initiatives like COMPASS and HepConnect sets it apart.

Upsides

Gilead's strategic partnerships expand its reach in inflammatory and oncology drug markets.

Investment in digital health technologies enhances Gilead's R&D and patient engagement.

Focus on sustainability improves Gilead's operational efficiency and corporate reputation.

Land your dream remote job 3x faster with AI

Try Jobo Free